About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder

NCT00613067·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Inje University

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

DSM-IV TR for GAD
Hamilton Rating Scale for Anxiety (HAMA) \>18
18 to 75 years old

You may not be if

Severe medical illness
Other psychiatric illness
HAMD \> 18
High suicidal risk
pregnancy

The record

StatusCompleted

PhaseNo phase

Taking part35

StartedDec 2007

UpdatedJun 30, 2010

Conditions

Generalized Anxiety Disorder

Where1

Psychiatry department, Inje Univ. Ilsanpaik Hospital
Goyang, Kyunggi, South Korea

Clareo Health | ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder